Revexepride is a selective 5-HT4 receptor agonist and potential CYP3A4 inducer, developed for gastroesophageal reflux disease (GERD) research. It is utilized in both in vitro binding assays and in vivo models to study gastrointestinal motility and drug metabolism interactions.
Molekulargewicht:
425.95
CAS Nummer:
[219984-49-3]
Formel:
C21H32ClN3O4
Target-Kategorie:
Cytochromes P450,Others,5-HT Receptor
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten